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Recent studies suggest that bone marrow stromal cells are a potential source of osteoblasts and chondrocytes and can be used to
regenerate damaged tissues using a tissue-engineering (TE) approach. However, these strategies require the use of an appropriate scaffold
architecture that can support the formation de novo of either bone and cartilage tissue, or both, as in the case of osteochondral defects.
The later has been attracting a great deal of attention since it is considered a difﬁcult goal to achieve. This work consisted on developing
novel hydroxyapatite/chitosan (HA/CS) bilayered scaffold by combining a sintering and a freeze-drying technique, and aims to show the
potential of such type of scaffolds for being used in TE of osteochondral defects. The developed HA/CS bilayered scaffolds were
characterized by Fourier transform infra-red spectroscopy, X-ray diffraction analysis, micro-computed tomography, and scanning
electron microscopy (SEM). Additionally, the mechanical properties of HA/CS bilayered scaffolds were assessed under compression. In
vitro tests were also carried out, in order to study the water-uptake and weight loss proﬁle of the HA/CS bilayered scaffolds. This was
done by means of soaking the scaffolds into a phosphate buffered saline for 1 up to 30 days. The intrinsic cytotoxicity of the HA scaffolds
and HA/CS bilayered scaffolds extract ﬂuids was investigated by carrying out a cellular viability assay (MTS test) using Mouse
ﬁbroblastic-like cells. Results have shown that materials do not exert any cytotoxic effect. Complementarily, in vitro (phase I) cell culture
studies were carried out to evaluate the capacity of HA and CS layers to separately, support the growth and differentiation of goat
marrow stromal cells (GBMCs) into osteoblasts and chondrocytes, respectively. Cell adhesion and morphology were analysed by SEM
while the cell viability and proliferation were assessed by MTS test and DNA quantiﬁcation. The chondrogenic differentiation of
GBMCs was evaluated measuring the glucosaminoglycans synthesis. Data showed that GBMCs were able to adhere, proliferate and
osteogenic differentiation was evaluated by alkaline phosphatase activity and immunocytochemistry assays after 14 days in osteogenic
medium and into chondrocytes after 21 days in culture with chondrogenic medium. The obtained results concerning the physicochemical
and biological properties of the developed HA/CS bilayered scaffolds, show that these constructs exhibit great potential for their use in
TE strategies leading to the formation of adequate tissue substitutes for the regeneration of osteochondral defects.
r 2006 Elsevier Ltd. All rights reserved.
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In the skeleton, articular cartilages allows a stable
movement with near frictionless and consequently act
as a unique protective interface for the underlying bone.
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compressive forces due to the ability to distribute loads
[1,2]. General features of cartilage tissue includes: (i) a
small number of chondrocytes with low proliferation rate
and having both catabolic and anabolic functions, (ii) a
high content of water where metabolites and a large
amount of electrolytes are dissolved, (iii) an abundant
extracellular matrix (ECM) composed by different types of
collagens (mainly type II) and proteoglycan aggrecan,
which is mainly responsible for the elasticity, and (iv)
possess no nerve and vascular systems [1,3]. Actually, the
different cell numbers, organization and distribution, as
well as organic and water content across cartilage are
responsible for the existence of three distinct layers with
respect to depth, i.e. superﬁcial, middle and deep [4]. In this
respect, Kuettner et al. [4] have suggested that the
variations among articular cartilages is mainly due to
signiﬁcant changes in biochemical composition and bio-
mechanical properties of the three layers.
It is well known that cartilage has a limited regeneration
capacity upon damage. In certain extent, this is explained
by the fact of being an avascular tissue; regenerative cells
cannot migrate to the defect void unless the lesion goes
beyond the subchondral bone plate [5,6]. Therefore, a
regenerative response will be only possible when it is
provided an artiﬁcial access by the marrow [7]. This
consideration is subjacent on several clinical strategies that
are currently employed on the treatment of small cartilage
lesions namely, the subchondral abrasion, Pridie perfora-
tions, micro-fracture, and transplantation of osteochondral
plugs [6,8–10]. Although, in most cases after clinical
intervention the repaired tissue tends to degenerate and
occur the formation of the undesired ﬁbrocartilage
[5,11,12]. More recently, it was reported an alternative
approach, which consists on injecting autologous chon-
drocytes at the defect void [13–15]. Even though, this
strategy does not avoid the excision of healthy cartilage
from the joint for further expansion of the freshly isolated
chondrocytes in vitro. Despite the encouraging results,
there are a few critical requirements for the success of this
approach. For example, the need to obtain high cell
numbers, while maintaining chondrocyte functions. In this
respect, it is well known [16,17] that conditions favouring
maintenance of phenotype are usually different from those
that favour a high cell density, and consequently there are
limitations in the number of cells obtained in vitro for
subsequent clinical application. Therefore, the low rate of
success especially in large lesions and in older people, and
the procedural constraints are the major drawback of these
techniques [18].
In order to eliminate donor site morbidity, which is one
the major limitation of autografts, several tissue-engineered
(TE) cartilaginous cell-scaffolds constructs have been
proposed [19,20]. But, since we have been able to gain
new insights related with the role of subchondral bone, it
seems obvious the enormous implications in the ﬁeld of TE
namely, in respect to the development of more adequatescaffolds architectures for cartilage healing. In this respect,
several authors have been proposing the use of bilayered
osteochondral constructs for the improved regeneration of
cartilage defects [21–23]. Basically, this conceptual ap-
proach consists on developing a single 3D porous structure
that combines a mechanical support resembling the
subchondral bone (bone-like layer), while also providing
a chondrogenic support in the top for the repairing of
cartilage (cartilage-like layer) [24,25]. Materials like hydro-
xyapatite (HA) [26–28] and chitosan (CS) [29–31] have
been widely employed to develop suitable 3D supports for
applications in TE of bone and cartilage, respectively.
Therefore, on the basis of the osteochondral approaches,
the development of bilayered osteochondral scaffolds
combining both HA and CS layers thus seems a good
approach. Although, a strong mechanical interface be-
tween mineral substrate and polymer matrix is required for
preventing a premature failure of the scaffold. Schek et al.
[25] has been described the use of poly lactic acid (PLA)
rods for connecting a HA and PLA phases of a biphasic
composite scaffold. Nevertheless, the effect of the poly-
meric rods on bone and cartilage regeneration is not
studied. Therefore, there is the need of more simple and
reliable strategies to manufacture bilayered scaffolds for
osteochondral applications.
Besides the choice of adequate materials and the
optimization of the mechanical properties and architecture
for the scaffolds, TE strategies requires the use of cell
sources, that should be viable in terms of clinical practice
and that can be effective in new tissue formation. Research
focused on tissue regeneration by means of using mesench-
ymal stem cells (MSCs) is increasingly attracting a great
deal of attention, since MSCs have the ability to
differentiate into various mesenchymal lineages [32–34]
under speciﬁc culture conditions [35]. In fact, MSCs are
one of the most promising candidates for transplantation
after seeding into TE implants [36–39].
In this study it is described the developmental route,
physicochemical characterization and biological evaluation
of novel 3D macroporous HA/CS bilayered scaffolds. HA
scaffolds (bone-like layer) were ﬁrstly produced by means
of sintering. Then, the CS porous layer (cartilage-like layer)
was obtained by means of freeze-drying a CS solution
poured onto the top of the HA scaffolds. The physico-
chemical characterization of both organic and inorganic
layers was performed by Fourier transform infra-red
(FTIR) spectroscopy, X-ray diffraction (XRD) analysis,
micro-computed tomography (m-CT), and scanning elec-
tron microscopy attached with an X-ray detector (SEM/
EDS). The mechanical properties of the HA, CS porous
layers and HA/CS bilayered scaffolds were assessed by
compression tests. In vitro tests were also carried out to
investigate the water-uptake and weight loss behaviour of
the HA/CS bilayered scaffolds by soaking into a phosphate
buffered saline (PBS) for 1 up to 30 days.
The intrinsic cytotoxicity of the HA porous layer and
HA/CS bilayered scaffolds leachables was examined by
ARTICLE IN PRESS
J.M. Oliveira et al. / Biomaterials 27 (2006) 6123–6137 6125carrying out a cellular viability assay (MTS test) using
Mouse ﬁbroblastic-like cells, which were previously in
contact with the different concentrations of the scaffolds
extract ﬂuids. Moreover, a preliminary in vitro cultivation,
proliferation and differentiation study was performed upon
seeding of goat bone marrow stromal cells (GBMCs) onto
HA and CS layers (Phase I). GBMCs have been shown to
present high proliferation and viability rates in fresh or
cryopreserved cultures. These cells are quite stable in 2D
cultures and differentiate into osteogenic and chondrogenic
phenotypic cells in the presence of supplemented osteo-
genic and chondrogenic media, respectively. Beside that, it
is possible to use an autologous approach with the goat
animal model and, in future experiments, evaluate in vivo,
the osteochondral constructs functionality of HA and CS
using marrow cells harvested from same animal implanted
with the in vitro TE construct. Relative GBMCs viability
and proliferation was assessed by MTS test and DNA
quantiﬁcation, while cellular adhesion and morphology
was investigated by SEM. Osteogenic differentiation was
assessed by alkaline phosphatase (ALP) activity and
immunocytochemistry techniques for type I collagen
and osteopontin. Glucosaminoglycans (GAGs) quantiﬁca-
tion assay was performed to evaluate chondrogenic
differentiation.
Future studies will be designed to investigate the
capacity of the HA/CS bilayered scaffolds to favour
simultaneous osteoblasts and chondrocytes proliferation
and differentiation upon seeding GBMCs, leading to the
formation of adequate tissue substitutes for the regenera-
tion of osteochondral defects. With this approach it is
aimed to develop an autologous model for further
implantantion in vivo.
2. Materials and methods
2.1. Synthesis of HA
Analytical reagent grade calcium hydroxide, Ca(OH)2 (Riedel-de Hae¨n,
Germany) and ortho-phosphoric acid, H3PO4 (Panreac, Spain) were used
on the synthesis of the HA powders. An controlled drop-wise automated
apparatus was developed by means of using a peristaltic pump (Gilson
Miniplus 3, France) for adding a diluted solution of ortho-phosphoric acid
to the calcium hydroxide solution, in a reaction vessel. Synthesis
conditions were adjusted to obtain a stoichiometric HA, i.e. Ca/P ratio
of 1.67. After complete addition of the acid solution, the ﬁnal pH of
medium was adjusted to 11 with concentrated ammonium hydroxide
(Riedel-de Hae¨n, Germany). Vigorous stirring was continued during HA
precipitation. The supernatant was removed after 24 h of maturation, and
the precipitate ﬁltered under vacuum. The resulting ﬁltrate was dried at
60 1C for 24 h and milled in a mortar until obtaining a ﬁne powder.
2.2. Preparation of HA scaffolds and HA/CS bilayered scaffolds
HA/CS bilayered scaffolds were produced by adopting a two step
procedure. Firstly, HA porous layer (bone-like layer) with 10mm height
and 8mm diameter were obtained by means of impregnating a
polyurethane (PU) sponge with HA powders, as previously reported by
Oliveira et al. [40]. The elimination of the organic matrix consisted on
burning the impregnated sponges in the furnace (Fornoceraˆmica-ATR901, Portugal) at 900 1C for 24 h, followed by sintering at 1300 1C for 3 h,
at ramp rate of 2.5 1Cmin1. Secondly, a 3wt% CS solution was prepared
by dissolving CS of medium molecular weight (Aldrich, Germany) and a
degree of deacetylation of 85% in 0.2M acetic acid solution. The
bilayered HA/CS scaffolds were fabricated by placing the HA scaffolds
into cylindrical silicon moulds (20 8mm) and transferring the 3wt% CS
solution. To guarantee that CS interpenetrated into the HA scaffolds it
was left resting for 1min at room temperature. Moulds were freeze at
80 1C and lyophilized (Telstar-Cryodos 80, Spain) up to 4 days to
complete remove the frozen solvent, and allow obtaining the ‘cartilage-like
layer’ on the top of the ‘bone-like layer’. Then, HA/CS bilayered scaffolds
were neutralized using a 0.1M sodium hydroxide solution as previously
described elsewhere [41], freeze at 80 1C and once lyophilized. Finally,
the resulting HA/CS bilayered scaffolds were sterilized using ethylene
oxide before carrying out the cell culture studies.
2.3. Physicochemical characterization
2.3.1. FTIR spectroscopy
Infra-red spectra of specimen powders were recorded on a Perkin-
Elmer spectrometer (Perkin-Elmer 1600 series equipment, USA). Prior
analysis transparent KBr (Riedel-de Hae¨n, Germany) pellets were
prepared by mixing in the ratio of 1:10 of sample/KBr (wt/wt), followed
by uniaxially pressing the powders under vacuum. All spectra were
obtained between 4400 and 450 cm1 at a 2 cm1 resolution.
2.3.2. XRD analysis
X-ray diffractometer (Philips PW 1710, The Netherlands) employing
Cu–Ka radiation was used to investigate the cristallinity and phase
content of the HA scaffolds on powder. Data was collected from 2 to 651
2y values, with a step size of 0.021, and a counting time of 2 s step1.
2.3.3. Surface topography characterization
The surface morphology and pore size of the HA scaffolds and HA/CS
bilayered scaffolds were examined under the SEM/EDS (Leica Cambridge
S-360, UK). Prior to the microstructure analysis, specimens were coated
with gold using a Fisons Instruments Coater (Polaron SC 502, UK) with a
current set at 18mA, for a coating time of 120 s.
2.3.4. Micro-computed tomography
The qualitative information of the HA/CS bilayered scaffolds
architecture was obtained by microtomography imaging using a Scanco
20 equipment (Scanco Medicals, Switzerland) with penetrative X-rays of
50 keV. The X-ray scans were acquired in high-resolution mode (11 mm).
Mimicss software (Materialise, Belgium) was used to visualize the 2D
X-ray sections images of the HA/CS bilayered scaffolds. From the CT
data set, 300 slices of a region of interest corresponding to the interface
between HA and CS was used to investigate the continuity of the HA/CS
bilayered scaffolds. A customized threshold technique was used to
enhance the CS contrast and remove noise.
2.3.5. Mechanical testing
Compression tests (dry state) were performed using a Universal Testing
Machine (Instron 4505) possessing a load cell of 50 kN, at room
temperature. The gauge length and diameter of all specimens was 16mm
and 8mm, respectively. Tests were conducted with a constant strain rate of
2mmmin1, and up to failure or until 60% reduction in specimen height.
The modulus (E) was determined by linear regression from the slopes in
the initial elastic portion of the stress-strain diagram. A minimum number
of 10 specimens were tested, and then E was averaged from the 10
measurements.
2.3.6. Water uptake and weight loss studies
Water uptake and weight loss of the HA scaffolds and HA/CS
bilayered scaffolds were evaluated after immersion into a PBS (Sigma-
Aldrich, Germany) solution at pH 7.4 for time periods up to 30 days.
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water uptake (WUs) after each time of immersion (t) was calculated using
Eq. (1), where Wd and Ww correspond to the weight of the HA/CS
bilayered scaffolds in dry and wet state, respectively:
WUs; t ¼ ½ðWw;t WdÞ=Wd  100. (1)
The percentage of weight loss (WLs) after each time of immersion (t)
was calculated using Eq. (2), where Wi and Wf corresponds to the weight
they before and after immersion into PBS solution, respectively:
WLs; t ¼ ½ðW f ;t W iÞ=W i  100. (2)
2.4. In vitro cell culture studies
2.4.1. Cytotoxicity screening
MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-
sulfophenyl)-2H-tetrazolium) test was performed to determine the
cytotoxicity of HA porous scaffolds and HA/CS bilayered scaffolds
leachables that might result from the processing methodology used to
obtain the HA scaffolds and/or leachables of the polymeric component of
the bilayered materials. Mouse ﬁbroblastic-like cells (L929 cells; ECACC,
UK), were cultured in basic medium: Dulbecco’s Modiﬁed Eagle’s
Medium (DMEM), Sigma-Aldrich, USA) without phenol red supplemen-
ted with 10% foetal bovine serum, FBS (Gibco, UK) and antibiotic-
antimycotic (1% A/B, Gibco, UK) solution containing 10,000 unitsml1
penicillin G sodium, 10,000mgml1 streptomycin sulphate and 25mgml1
amphotericin B as Fungizones in 0.85% saline. L929 cells were incubated
at 37 1C in an atmosphere containing 5% of CO2, and after achieving
conﬂuence a cell suspension was prepared with a concentration of
8 104 cellsml1 and seeded onto 96-well plates. L929 cells were
incubated for 3 days with different concentrations of HA and HA/CS
bilayered scaffolds extracts (25%, 50%, 75% and 100%). Eight replicates
were considered per sample. Extracts of all samples were prepared as
previously described by Gomes et al. [42].
L929 cells relative viability (%) was determined for each extract
concentration and compared to tissue culture polystyrene (TCPS). Latex
extracts were used as a positive control of cellular death. All cytotoxicity
tests were performed in triplicate.
2.4.2. Isolation and culture of GBMCs
Bone marrow stromal cells were isolated from the iliac crest of adult
goats and cultured with basic culture medium—DMEM supplemented
with 10% FBS and 1% A/B. Cells were cultured until conﬂuence and sub-
cultured at P1 and P2 before seeding. The relative viability of GBMCs on
the HA scaffolds was also determined by carrying out an MTS assay, after
each time point. For this purpose, cells-HA scaffold constructs were
transferred into a 48-well plate and washed twice with sterile PBS. Culture
medium without FBS and without phenol red was mixed with MTS in a
5:1 ratio, added to the wells, until totally cover the constructs, and
incubated for 3 h at 37 1C in a 5% CO2 incubator. After the incubation
period, 100ml of MTS and medium mixture were transferred into each well
of a 96-well plate and absorbance was read at 490 nm.
2.4.3. Seeding of GBMCs onto the HA porous layer and 3D culturing
(Phase IA)
GBMCs cells were enzymatically lifted with 3ml of trypsin after
reaching 80% of conﬂuence at P1 or P2. A cell suspension was prepared
and seeded onto the HA porous layer in a scaffold drop-wise manner, at a
cellular density of 2.1 105 cellsml1. Cells/scaffolds constructs were
cultured in 48-well plates for 3 days with basic medium in static
conditions. For inducing osteogenic differentiation, cell-seeded scaffolds
were cultured with an osteogenic media consisting of alpha-MEM
(Minimal Essential Medium Eagle alpha modiﬁcation, Sigma-Aldrich,
USA) supplemented with osteogenic supplements namely, 108 M dex-
amethasone (Sigma-Aldrich, USA), 50 mgml1 ascorbic acid (Sigma,
USA) and 10mM b-glycerophosphate (Sigma, USA). The constructs werecultured for 3 days in static cultures with basal medium plus 14 days in
osteogenic medium (17 days) and under dynamic conditions by using a lab
rotator (Model DSR 2800V, Digisystem Laboratory Instruments Inc.,
Taiwan). Samples were collected on day 0 (12 h after seeding), day 3 and
day 17 for further studies.
2.4.4. Seeding of GBMCs onto the CS porous layer and 3D culturing
(Phase IB)
To induce chondrogenic differentiation, CS scaffolds were seeded with
2.5 105 cells and cultured for 7, 21 and 28 days with chondrogenic
medium consisting of DMEM (Sigma-Aldrich, USA) supplemented with
10Zgml1 TGF-b (Sigma-Aldrich, USA), ITS+1 (100 liquid media
supplement, Sigma, USA), 0.1M sodium pyruvate (Sigma-Aldrich, USA),
35mM proline (Sigma-Aldrich, USA), 17mM ascorbic acid (Sigma-
Aldrich, USA) and 1mM dexamethasone (Sigma-Aldrich, USA). The
cell-scaffold constructs were also cultured under dynamic conditions by
using a lab rotator system. Samples were retrieved after 7, 21 and 28 days
of chondrogenic culture. Before chondrogenic medium was added,
samples were cultured for 3 days in basal medium in static conditions.
In both cases, culture media were changed every 2–3 days.
2.4.5. Evaluation of GBMCs adhesion and morphology
Culturing GBMCs adhesion and morphology was investigated by SEM
analysis. For this purpose, after each culturing period, samples were
removed from culture, washed in PBS, ﬁxed in 2.5% glutaraldehyde,
rinsed two times with PBS and dehydrated in series of ethanol
concentrations. The samples were then dried at room temperature and
sputter coated with gold before observation under the SEM.
2.4.6. Assessment of GBMCs proliferation and differentiation
GBMCs-HA and -CS construct celullarity was determined using a
ﬂuorimetric dsDNA quantiﬁcation kit (PicoGreen, Molecular Probes).
For this purpose, samples collected on days 0, 3 and 17, were washed twice
with a sterile PBS (Sigma, USA) solution and transferred into 1.5ml
microtubes containing 1ml of ultra-pure water. GBMCs-HA and -CS
were incubated for 1 h at 37 1C in a water-bath and then stored in a 80 1C
freezer until testing. Prior to DNA quantiﬁcation constructs were thawed
and sonicated for 15min. Samples and standards (ranging between 0 and
2mgml1) were prepared per each well of an opaque 96-well plate were
added 28.7ml of sample or standard plus 71.3ml of PicoGreen solution and
100ml of Tris–EDTA buffer. Triplicates were made for each sample or
standard. The plate was incubated for 10min in the dark and ﬂuorescence
was measured on a microplate ELISA reader (BioTek, USA) using an
emission of 490 nm and an absorbance wavelength of 520 nm. A standard
curve was created and sample DNA values were read off from the
standard graph.
ALP activity was measured to evaluate osteoblastic differentiation.
Cell-HA scaffold constructs used for DNA quantiﬁcation assay were used
to determine ALP levels. As cells were lysed during the above-mentioned
procedure, both DNA and other cell-produced proteins were in
suspension in the supernatant solution. So, to each well of a 96-well plate
were added 20 ml of sample plus 60ml of substrate solution: 0.2% (w/v) p-
nytrophenyl (pNP) phosphate (Sigma, USA) in a substrate buffer: 1 M
diethanolamine HCl (Merck, Germany), at pH 9.8. The plate was then
incubated in the dark for 45min at 37 1C. After the incubation period,
80ml of a stop solution: 2M NaOH (Panreac, Spain) containing 0.2mM
EDTA (Sigma, USA), was added to each well. Standards were prepared
with 10 mmolml1 pNP and the stop solutions in order to achieve the ﬁnal
concentrations ranging between 0 and 0.3mmolml1. Triplicates were
made for each sample and standard. Absorbance was read at 405 nm and
sample concentrations were read off from standard graph.
Immunocytochemistry technique was performed by ﬁxing cell-HA
scaffold constructs in an Accustain formalin solution, 10% neutral
buffered (Sigma-Aldrich, USA) for 1 h at 4 1C, washing with PBS and
including the constructs into methacrylate blocks. These blocks were
cut into 10mm thick slides and kept overnight at 80 1C before being
used for subsequent immunocytochemistry analysis. The procedures
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in commercial kit: the RTU Vector Stain kit-Universal Elite ABC kit
PK7200 (Vector Laboratories Inc., USA). This kit was used with a
Peroxidase Substract Kit-DAB SK4100 (Vector Laboratories Inc.,
Burlingame, USA). For this study, samples were incubated with collagen
type I (1/100, Chemicon, USA) for 1.6 h and the biotinylated secondary
antibody was incubated for 1 h prior to wash and incubate the constructs
with DAB for about 6min. Also an osteopontin antibody (1/100, Rabitt
polyclonal to osteopontin, Abcam, UK) was tested using slides from the
same constructs. Although in this particular case, a ﬂuorescent secondary
antibody was used instead of a biotinylated one and kept overnight at
80 1C. The metacrylate sections were incubated with osteopontin antibody,
washed and then Alexa Fluor 488 secondary antibody (Molecular Probes,
Invitrogen, UK) was added to cell-HA scaffold constructs. The incubation
periods used were the same for both collagen type I and osteopontin
antibodies. The observation of the constructs was performed using an
Axio Imager Z1 microscope (Zeiss, Germany).
GAGs quantiﬁcation assay [43] was used to determine extracellular
chondrogenic matrix formation after days 7, 21 and 28 of chondrogenic
medium culture. Cell-CS scaffold constructs used for this assay were the
same used for ALP and DNA assays. GAGs standards were obtained by
preparing a chondroitin sulphate solution ranging from 0 and 30mgml1.
In each well of a 96-well plate, 20 ml of sample or standard were added in
triplicates and then 250ml per well of dimethylmethylene blue (DMB,
Sigma-Aldrich, USA) was added and mixed. The optical density was
measured immediately at 525 nm on a microplate ELISA reader. A
standard curve was created and GAGs sample values were read off from
the standard graph.Fig. 1. Macroscopic appearance of the HA/CS bilayered scaffolds.3. Results and discussion
3.1. Characterization
The exploitation of a variety of biomaterials and
cultured cells in TE approaches offers a wide range of
possibilities for the successful repair of different skeleton
damages. The ideal strategy for the treatment of osteo-
chondral defects requires a scaffold architecture possessing
a ‘cartilage-like’ layer (upper layer) and a ‘bone-like’ layer
(bottom layer) [44]. With this approach, the porous
bilayered structure is expected to act as a support for cells
functions and ultimately, leading to the de novo formation
of an articular cartilage-like tissue in the cartilage void,
while providing a good ﬁxation on the underlying bone.
Previously, it was shown [45] that it is possible to develop
a 3D macroporous HA structures by impregnation of PU
sponges with HA particles, followed by burning the
organic template and sintering the ceramic at 1300 1C.
Moreover, it is well known that a wide number of highly
porous scaffold systems may be prepared by means of
freezing a polymer solution and subsequently freeze-
drying. In this study, we developed a novel bilayered
scaffold by means of pouring a 3wt% CS solution upon
the sintered HA scaffolds followed by a freeze-drying
procedure. Fig. 1 shows the macroscopic appearance of the
HA/CS bilayered scaffolds. The macro image shows two
distinct layers, which corresponds to HA (bottom layer)
and CS (upper layer). The improved stability at the
inorganic–organic interface and overall integrity of the
HA/CS bilayered scaffolds was achieved by partiallyimpregnating the porous ceramic layer with the polymeric
one.
Fig. 2 shows the FTIR spectra of the HA and CS layers
of the HA/CS bilayered scaffolds. The FTIR analysis
revealed the presence of the typical bands of CS on the
upper layer namely, the absorption bands of the amide I
and amide II groups at 1650 and 1586 cm1 (y), respec-
tively [46,47]. On the other hand, the IR spectrum also
exhibited the peaks at 900 and 1155 cm1 (K) associated to
saccharine structure, and aliphatic C–H stretching bands in
the region of 2996–882 cm1 ( ). The more intense and
broad absorption band in the CS is attributed to the N–H
stretching and O–H stretching vibration (’) located in the
spectral region of 3200–3500 cm1.
Regarding the FTIR spectrum of lower layer of the HA/
CS bilayered scaffolds, it were detected intense absorption
bands at 598 and 559 cm1 (+), and 1020 cm1 (&), which
are assigned to phosphate groups with the frequency of
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J.M. Oliveira et al. / Biomaterials 27 (2006) 6123–61376128vibration n4 and n3, respectively. The small and sharp band
observed at 3572 cm1 (0) corresponds to the stretching
mode of hydroxyl group, which is characteristic of calcium
phosphates such as HA [48]. The FTIR data showed no
typical peaks of the PU sponge in the HA layer after
performing the heat treatments. This result is an important
one, because it shows that no traces of PU sponge were
present in the HA layer, thus avoiding the presence of
organic matter that somehow could be responsible for
eliciting some cytotoxic effect. Therefore, this result has
shown that by means of using the burning and sintering
cycle herein described, it is possible to completely eliminate
the ‘sacriﬁce matrix’ consisting of PU sponge.
It has been reported that at temperatures higher than
1200 1C, HA became unstable and frequently loses the
–OH groups, and transforms decomposition products such
as b-tricalcium phosphates (TCP) [48,49]. When the
temperature exceeds 1250 1C, an allotropic transformation
may also occur and b-TCP may originate a-TCP [48,49].
Although, in a previous work we have shown that the
synthesized HA is highly stable upon sintering at 1300 1C
for 3 h, i.e. no –OH group loss was detected and no phase
transformation observed [45]. Thus, understanding the
sintering behaviour of HA allows us to control the
chemical composition and design a porous ceramic
structure with controlled grain size, microstructure and
mechanical properties, since sintering temperature also has
a dramatic effect on densiﬁcation. Actually, it has been
shown that a decrease in porosity, i.e. increase in particle
agglomeration is accompanied by an increase in the
mechanical strength, due to the homogeneity and more
closed packed HA grains [50].
In this study, the XRD was also used to investigate the
crystallinity and phase content of inorganic layer of the
HA/CS bilayered scaffolds. Fig. 3 shows the XRD pattern
of the ceramic porous layer (on powder) after burning the
organic template at 900 1C followed by sintering at 1300 1Cfor 3 h. The XRD data is in good attainment with the
FTIR, showing that the ceramic layer consists of highly
crystalline form of HA [51,52]. As expected, the pouring
and freeze-drying of a CS solution upon the ceramic
porous layer did not affect both crystallinity and phase
content of the HA.
From the SEM images shown in Fig. 4, it can be seen
that HA/CS bilayered scaffolds microarchitecture consists
of a highly porous and open pore structure. Fig. 4A shows
the interface of HA/CS bilayered scaffold at the surface,
where it is possible to observe the two distinct porous
layers. Fig. 4B shows a typical HA pore at the HA/CS
interface, showing the good interpenetration of CS into the
HA scaffolds. This observation suggests that a good
bonding exist between the two layers, which is known to
be a requisite necessary to assure a good integrity and
functionality of the osteochondral construct (scaffold+
cells). Moreover, the SEM examination of the HA
scaffolds revealed that pores are highly interconnected
and possess a size diameter in the range of 50–500 mm
(Fig. 4C).
Several authors [53,54] have shown that freezing condi-
tions, concentration of polymer and freeze-drying para-
meters has great inﬂuence on the ﬁnal microstructure and
degree of interconnectivity of the scaffolds. Fig. 4D shows
the SEM micrograph of a CS pore at the typical transversal
cross-section of CS layer. This study revealed that CS pores
quite resembles a typical spongy 3D structure, with open
pores, anisotropic porosity and pore size ranging from
20–600 mm. It is also possible to observe the formation of
micro ﬁbres during the freeze-drying process. This can be
an advantage since these ﬁbres can act as an additional
anchor-framework for improved cells adhesion. Therefore,
the results depicted in Fig. 4 have shown that by combining
a sintering and freeze-drying technique it is possible to
develop HA/CS bilayered scaffolds with an adequate pore
size and pore distribution for ingrowths of cells and
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Fig. 4. SEM micrographs of the HA/CS bilayered scaffolds: interface (A), typical pore at interface (B), pore of HA scaffolds (C) and pore of CS layer (D).
J.M. Oliveira et al. / Biomaterials 27 (2006) 6123–6137 6129diffusion of nutrients, while facilitating vascularization,
and thus to be used in TE purposes [55,56]. Although, it is
noteworthy that SEM analysis is only a reliable technique
to obtain information about 2D systems, i.e. investigate the
macro and micro-structure of the scaffold in a non-
destructive way at the surface, and shows limited perfor-
mance for assessing the pore interconnectivity of the
materials. Moreover, the scaffold should be sectioned by
destructive techniques towards obtaining the detailed
information of their inner part using the SEM, thus the
original morphology of the scaffold will be destroyed.
Therefore, in this study the 3D architecture of the materials
was investigated in a non-destructive way, by means of
using a micro-CT analysis.
Fig. 5 shows the m-CT analysis of the HA/CS bilayered
scaffolds. A customized threshold technique was carried
out and has shown to be effective on assessing the pore size
and interconnectivity of CS (Fig. 5A). From the m-CT 2D
scans it was possible to assess that pore size is higher than
those obtained by the SEM (surface study). Actually, the
inner pores of CS was assessed to be up to 2mm in length,
which may be explained by the fact that m-CT allows to
study the inner 3D architecture of the materials. Fig. 5B
shows the 2D transversal view of the HA scaffolds, which
corroborated the SEM ﬁndings. This results clearly showedthat the HA pore network is highly interconnected. From
Fig. 5C it became possible to observe that CS perfectly
interpenetrated into the HA, thus showing the good
continuity of the HA/CS bilayered scaffold. This result is
encouraging since a strong mechanical interface between
the HA and CS is required for the good performance of the
construct.
Previous reported results have shown that the mean
porosity of the HA scaffolds (bottom layer) of the HA/CS
bilayered scaffolds consisted of 67.875.1% [45]. In this
study, the percentage of porosity of the HA and CS layers
were also determined (Fig. 5D). The results have shown
that HA possess a porosity of 59.371.7%, which is in good
agreement with the previous reported data, and that CS
layer consisted of 74.671.2%. Therefore, the HA/CS
bilayered scaffolds have shown to possess adequate
porosity [56] towards being used in TE scaffolding.
Despite, the percentage of porosity at the interface was
not possible to determine due to the limitation of the
technique, i.e. since the coefﬁcient of attenuation of HA is
much higher that that of CS, the threshold applied for
determining the porosity of HA layer (T300) is different
from that for assessing the porosity of CS layer (T55). In
fact, the observation of the dramatic lowering of porosity
of CS layer at the interface consists of an artefact and is a
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Fig. 5. m-CT images of the HA/CS bilayered scaffolds: transversal view of the CS scaffold (A), transversal view of the HA scaffold (B), and longitudinal
view of the interface between HA (bottom layer) and CS (top layer) (C), and respective percentage of porosity.
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also shows that the overall integrity of the HA/CS
bilayered scaffolds was achieved by partially impregnating
the porous ceramic layer with the polymeric one, and is
restricted to an area of 750 mm in length. Moreover, the
results have shown that a physical interaction is responsible
for the stability of the bilayered scaffolds at the interface
between HA and CS. Therefore, another biopolymer thatcan be processed by freeze-drying may serve the same role
as the CS, i.e. top layer of the bilayered scaffold.
To examine the mechanical properties of the HA/CS
bilayered scaffolds, compression tests of the two layers
were conducted separately, in dry conditions. The modulus
(E) for the HA and CS in compression was found to be
153712 and 2.970.4MPa, respectively. This results show
that HA scaffold possess quite good mechanical properties
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CS scaffolds are in good attainment with those for normal
human articular cartilage, which has been shown to have a
compressive modulus ranging from 1.9 to 14.4MPa [57,58].
Thus, the HA/CS bilayered scaffolds demonstrated quite
promising mechanical properties for being used in TE of
osteochondral defects. Actually, it has been shown that the
biomechanical properties of articular cartilage greatly
depends on composition, density of its ECM and
interstitial ﬂuid ﬂow (water and solutes) [59]. Therefore,
in wet conditions is expected a reduction of the mechanical
properties. However, it must be noted that after implanta-0 5 10
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Fig. 6. HA/CS scaffolds after soaking in PBS solution for times rangtion of the construct we expect to occur a matrix deposition
and accumulation mediated by the cells, i.e. chondrocytes
in the case of cartilage, and by this mean improve the
mechanical function of the engineered cartilage [60].
The capability of a scaffold to uptake and preserve the
water within the structure is an important feature for
developing suitable TE constructs for regeneration of both
cartilage and osteochondral defects, since cartilage pos-
sesses a high content of water where oxygen and nutrients
are dissolved. The water uptake and weight loss of the HA/
CS bilayered scaffolds was investigated after soaking
in PBS solution at physiological pH, for 1 up to 30 days15 20 25 30
 time (days)
15 20 25 30
 time (days)
ing from 1 up to 30 days: water uptake (A) and weight loss (B).
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proﬁle of the HA/CS scaffolds reach a maximum of
swelling of approximately 65% (w/w), after 5 days. From
day 5 until day 30 the water uptake capability of the HA/
CS remained constant (Fig. 6A). After immersion of HA/
CS bilayered scaffolds in PBS, no signiﬁcant changes on
the weight loss were observed. In fact, the weight loss
proﬁle showed that from day 3 until day 30, the HA/CS
scaffolds showed a reduction in weight of approximately
0.8% (Fig. 6B). It has been demonstrated that HA
dissolves slowly, both in vitro and in vivo [61,62]. There-
fore, this gradual weight loss should be mainly due to the
slow loss of the highly hydrophilic CS scaffold by a
solution-mediated dissolution, i.e. leaching of the water
solubles rather than HA scaffold. A decrease in CS
molecular weight lowers the water-uptake and favours
dissolution [63]. Thus, the overall performance of the HA/
CS scaffolds may be easily tailored by using different
formulations namely, varying the CS molecular weight and
cross-linking [41]. Nevertheless, these results are quite
interesting since the HA/CS bilayered scaffolds has shown
to have enough stability, and preserve their size and
physical integrity. This evidences their good performance
for applications in TE of osteochondral defects and
subsequent implantation.3.2. Cytotoxicity screening for the HA scaffolds and HA/
CS bilayered scaffolds
The intrinsic cytotoxicity of the HA scaffolds and HA/
CS bilayered scaffolds was assessed by culturing L929 cells
with extract ﬂuids for 72 h. As observed in an inverted
microscope cells exhibited a normal morphology prolifer-
ated well and established a monolayer (data not shown).25% 50% 75% 100% Latex
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Fig. 7. Cytotoxicity screening for the HA scaffolds and HA/CS bilayered
scaffolds. L929 cells were incubated with different concentrations of
leachables obtained from HA scaffolds, HA/CS bilayered scaffolds, and
latex (positive control).Fig. 7 shows the cell viability assessed by carrying out the
MTS test. From the results it is possible to assess that cells
are viable in the presence of the HA and HA/CS scaffold
leachables. In fact, the viability levels are similar among
different HA and HA/CS concentrations, reaching the
maximum viability of 100%. This shows that both HA
scaffolds and HA/CS scaffolds do not exert any cytotoxic
effect on L929 cells. On the contrary, Latex rubber results
(positive control) performed in the same conditions; do not
overtake 1.0% of viable cells.
3.3. In vitro assessement of GBMCs adhesion, proliferation
and differentiation
The current investigations using biodegradable implants
seeded MSCs have shown to be effective on the repair of
osteochondral defects, in vivo [19]. In this work, we ﬁrst
analysed the ability of the HA porous layer to successfully
support the GBMCs adhesion and functions, in vitro
(Phase IA). As mentioned above, when treating osteochon-
dral defects this ‘bone-like’ layer is aimed at provide the
repair of the subchondral bone [64], while providing a good
ﬁxation on the underlying bone, during cartilage regenera-
tion. Fig. 8 shows the SEM micrographs obtained from
samples resulting from culturing GBMCs onto the HA
porous layer in osteogenic medium, for 14 days. It is
possible to observe the high cellular density on the surface
of the HA porous layer, which indicates that cells adhered
and grew favourably (Fig. 8A). Additionally, it is also
possible to observe that cells did not obstruct the pores of
the scaffold at the surface (Fig. 8B), and perfectly adhere,
spread actively and presented a ﬂatten morphology onto
the surface of the biomaterial (Fig. 8C). In fact, the
transversal section analysis indicates that cells were able to
penetrate deeper into the scaffold core (Fig. 8D). This is an
important observation since a good cell distribution within
the whole scaffold greatly affects the overall performance
of the construct (e.g. not limiting the diffusion of nutrients
and oxygen) and shows that scaffold architecture allowed
cells ingrowths and a sufﬁcient diffusion of nutrients.
Additionally, the formation of cells micovilli is also
observed, which is suggestive of cell activation [65]. In
our opinion, this result is quite promising since it
demonstrates that the HA porous layer possess an
adequate pore size and pore distribution to effectively
allow the cells to adhere and maintain their functions.
Analysis of DNA values showed a signiﬁcant enhancement
comparatively to initial time points (Fig. 9). The cell
number increased, and hence a high cellular proliferation
occurred in the presence of osteogenic media. The DNA
biochemical analysis was corroborated by MTS assay
(Fig. 10) showing that cells not only proliferated well in
HA porous layer but also were viable. These results
illustrate that HA porous layer is a suitable 3D support
for cellular proliferation. The functional activity of the
GBMCs on the HA porous layer was determined by
quantifying the ALP activity (Fig. 11). From days 0 to 3,
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Fig. 8. SEM micrographs of the HA scaffold seeded with GBMCs and cultured for 14 days in osteogenic media: surface of the cell-HA constructs (A, B),
GBMCs inﬁltration into a HA macropore (C), and GBMCs on the core of the HA scaffolds (D).
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Fig. 9. DNA content of GBMCs cultured on the HA scaffolds versus
culture time.
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Fig. 10. Proliferation levels of GBMCs on the HA scaffolds after 3 and 14
days of osteogenic culture, as assessed by an MTS method.
J.M. Oliveira et al. / Biomaterials 27 (2006) 6123–6137 6133cells were not cultured with osteogenic medium; so, ALP
levels refer only to basal levels of ALP activity in GBMCs.
Although, the higher ALP results shows that there is an
enhancement of the osteoblastic phenotype expressionlevels, which evidences the presence of osteoblast cells,
after 14 days (day 17) of culturing in the osteogenic
medium (Fig. 11). Fig. 12 shows the immunocytochemistry
preliminary results for cell-HA scaffold constructs after 14
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osteopontin, which demonstrates that osteoblast differen-
tiation was achieved in these constructs (Fig. 12A).
Immunolabeling for collagen type I was also detected,
thus showing the production of collagenous matrix
(Fig. 12C). Therefore, this data conﬁrm that GBMCs were
able to differentiate in the HA layer after culturing in an
osteogenic media for 14 days.
GBMCs seeded onto CS layer present a good viability
and proliferation (data not showed). SEM micrographs
show the attachment of cells possessing size and shapeDay 0 Day 3 Day 17
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Fig. 11. ALP activity assay of GBMCs cells cultured on the HA scaffolds.
Fig. 12. Immunolabeling for osteopontin marker (A) and respective negative
days of culturing. Immunolabeling for collagen type I marker (C) and resp
constructs after 14 days of culturing.consistent with those of chondrocytes throughout the
scaffolds, i.e. round chondrocyte-like cells (Fig. 13). It is
also possible to observe a good distribution of cells and
maintenance of the rounded cell morphology after day 28
(Fig. 13A). At higher magniﬁcation the moderate cell
adhesion to the substrate can also be seen (Fig. 13B), which
is generally indicative of a cell performing its differentia-
tion function [66]. Despite, cell numbers and penetration
within scaffolds appeared to improve in areas presenting
larger and interconnected pores.
Glycosaminoglycans (GAGs) are an important compo-
nent of proteoglycan and are typically present in the
cartilaginous ECM [67]. GAGs content was determined to
assess the formation of newly formed ECM and thus if
occur the differentiation of GBMCs into chondrocytes in
these cell-scaffold constructs, at days 7, 21 and 28 (Fig. 14).
The biochemical analysis demonstrated that the content of
GAGs increased from days 7 to 21, indicating that occur
biosynthesis due to the differentiation of the GBMCs into
the chondrogenic lineage. GAGs levels seems to be low;
however it was not found in the literature any reference
values to compare with. Nevertheless, CS scaffolds
obtained by a freeze-drying technique suggested to be a
suitable 3D support for chondrogenic differentiation of
GBMCs, and their maintenance over a period of 28 days.
Future studies will be designed to investigate the capacity
of the HA/CS bilayered scaffolds to favour simultaneous but
independent osteoblasts and chondrocytes proliferation and
differentiation upon seeding GBMCs, leading to the forma-
tion of adequate tissue substitutes for the regeneration ofcontrol (without antibody) (B) on the cell-HA scaffold constructs after 14
ective negative control (without antibody) (D) on the cell-HA scaffold
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Fig. 13. SEM micrographs of the CS layer seeded with GBMCs after 28 days of culturing (A, B).
J.M. Oliveira et al. / Biomaterials 27 (2006) 6123–6137 6135osteochondral defects (Phase II). This will be achieved using a
culturing system such as the ones proposed by Martin et al.
[68], which are speciﬁcally designed for this purpose and
allow to culture simultaneously the HA and CS layers in
separate culture medium that will direct cell differentiation
into the required phenotypes.
4. Conclusions
This work demonstrates the feasibility to prepare
hydroxyapatite/chitosan bilayered scaffolds by means ofan innovative method that combines a sintering and a
freeze-drying technique. The novel 3D-macroporous hy-
droxyapatite/chitosan bilayered scaffolds exhibit physico-
chemical properties that appear to make them a suitable
candidate to be used as a supportive structure for cells
functions. Moreover, the in vitro cell culture studies
demonstrated that both HA and CS layers provide an
adequate 3D support for the attachment, proliferation and
differentiation of GBMCs into osteoblasts and chondro-
cytes, respectively. The HA/CS bilayered scaffolds are
advantageous by several reasons, namely, they can be
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J.M. Oliveira et al. / Biomaterials 27 (2006) 6123–61376136designed with several sizes and controlled architecture to ﬁt
patient speciﬁc injuries and cell functions, respectively. The
HA/CS bilayered scaffolds showed promising biological
behaviour and may therefore ﬁnd applications in tissue
engineering of bone and osteochondral defects.
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